Patients demographics and clinico-biologic characteristics according to treatment received
| . | AlloSCT . | AuSCT . | HDARAC . | P . |
|---|---|---|---|---|
| n | 131 | 111 | 19 | |
| Median age (range) | 46.7 (18-60.9) | 48.4 (18-60.8) | 54.7 (27-59.5) | .033 |
| Sex, n (%) | ||||
| Male | 66 (50) | 59 (53) | 10 (53) | .909 |
| Female | 65 (50) | 52 (47) | 9 (47) | |
| Median WBC (range) | 12.9 × 109/L (0.16-352) | 16.7 × 109/L (0.90-186) | 11.6 × 109/L (1.24-102) | .462 |
| Risk category, n (%) | ||||
| NCCN-FR | 1 (1) | 78 (71) | 18 (95) | <.001 |
| NCCN-IR | 41 (32) | 20 (18) | 1 (5) | |
| NCCN-PR | 87 (66) | 1 (1) | 0 (0) | |
| NCCN-IR-no LAIP | 2 (1) | 12 (10) | 0 (0) |
| . | AlloSCT . | AuSCT . | HDARAC . | P . |
|---|---|---|---|---|
| n | 131 | 111 | 19 | |
| Median age (range) | 46.7 (18-60.9) | 48.4 (18-60.8) | 54.7 (27-59.5) | .033 |
| Sex, n (%) | ||||
| Male | 66 (50) | 59 (53) | 10 (53) | .909 |
| Female | 65 (50) | 52 (47) | 9 (47) | |
| Median WBC (range) | 12.9 × 109/L (0.16-352) | 16.7 × 109/L (0.90-186) | 11.6 × 109/L (1.24-102) | .462 |
| Risk category, n (%) | ||||
| NCCN-FR | 1 (1) | 78 (71) | 18 (95) | <.001 |
| NCCN-IR | 41 (32) | 20 (18) | 1 (5) | |
| NCCN-PR | 87 (66) | 1 (1) | 0 (0) | |
| NCCN-IR-no LAIP | 2 (1) | 12 (10) | 0 (0) |